Michael Gregory is co-managing partner of Avidity Partners, a biotechnology/healthcare-focused investment manager with a seasoned research team of six investment professionals with substantial scientific and investment expertise, and investments in public and private companies.  

From 2010-2018, Mr. Gregory was portfolio manager and head of Healthcare at Highland and managed an investment team of eight to 10 people and an average gross market value of $1 billion to $2 billion. He also served as CIO of the $4 billion alternative Investment platform and served as a member of the Equity Investment Committee, Private Equity Investment Committee, Credit Investment Committee and Executive Committee. In 2006, Mr. Gregory founded Cummings Bay, a biotechnology/healthcare-focused investment manager that became an affiliate of Highland in 2010. 

Mr. Gregory holds an MBA from the Yale School of Management, having completed a highly specialized joint program in healthcare within the Yale Schools of Medicine, Management and Public Policy. He holds a BS in Economics from the University of Pennsylvania, Wharton School of Business. He is a Fellow of the Royal Society of Medicine, lecturer at Yale University and serves on a number of academic and scientific boards including University of Texas Southwestern Medical Center, The University of Texas Center for Brain Health, The Center for Vision Health, Dallas Services, University of Texas Southwestern Cary Council (Steering Committee) and had prior Board appointments at University of Pennsylvania Center for Brain Injury and Repair, Southern Methodist University and Tower Center.